Did Mark Lanier win, or did Merck lose?
Many Monday-morning quarterbacks are clustered around Merck's whopping $253 million defeat of Friday afternoon, notes The Wired GC. Confessing that some of his friends still miss the Vioxx painkiller noted in the case, our GC wonders whether "this case may have been lost long before it started." He asks,
"Once Merck withdrew Vioxx from the market, in a move they probably thought would be strategically sound (and perhaps even publicly praised), every word written or spoken about Vioxx was put under a different microscope than Merck was familiar with. People who do drug research are focused on finding cures and enhancing treatments, not writing exhibits for their depositions ..."
What do you think? Here's the story I pulled off the Law.com newswire: Merck Ponders Grounds for Appeal in Wake of $253M Vioxx Verdict
Posted by Laurel Newby on August 22, 2005 at 02:23 PM | Permalink
| Comments (1)
| TrackBack (0)
TrackBack URL for this entry:
Listed below are links to weblogs that reference Did Mark Lanier win, or did Merck lose? :